RZC vs RYTM: Which is Better to Buy in 2026?

Side-by-side fundamental comparison based on AI analysis of SEC filings

AI Verdict

RZC has stronger fundamentals based on our AI analysis.

RZC
REINSURANCE GROUP OF AMERICA INC
BUY
78%
Confidence
VS
RYTM
RHYTHM PHARMACEUTICALS, INC.
SELL
78%
Confidence

RZC vs RYTM Fundamental Comparison

Metric RZC RYTM
Revenue $23.7B $189.8M
Net Income $1.2B $-196.5M
Net Margin 5.0% -103.6%
ROE 8.8% -141.3%
ROA 0.8% -40.9%
Current Ratio N/A 4.41x
Debt/Equity 0.42x 0.73x
EPS $17.69 $-3.11

Green = Better metric | Red = Weaker metric

View Full RZC Analysis →
View Full RYTM Analysis →
Browse Sectors: Technology Healthcare Finance Energy Consumer Industrial
Stock Lists: Strong Buy Undervalued Growth Dividend

You Might Also Compare

RZC vs AAPL RYTM vs MSFT RZC vs GOOGL RYTM vs AMZN

RZC vs RYTM: Frequently Asked Questions

Is RZC or RYTM a better buy in 2026?

Based on dual AI fundamental analysis (Claude and ChatGPT), RZC has stronger fundamentals. RZC is rated BUY (78% confidence) while RYTM is rated SELL (78% confidence). This is not investment advice.

How does RZC compare to RYTM fundamentally?

REINSURANCE GROUP OF AMERICA INC has ROE of 8.8% vs RHYTHM PHARMACEUTICALS, INC.'s -141.3%. Net margins are 5.0% vs -103.6% respectively.

Which stock pays higher dividends, RZC or RYTM?

RZC has a dividend yield of N/A or no dividend while RYTM has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.

Should I invest in RZC or RYTM for long term?

For long-term investing, consider that RZC has BUY rating with 78% confidence, while RYTM has SELL rating with 78% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.

What do the AI models say about RZC vs RYTM?

Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For RZC vs RYTM, the AI consensus favors RZC based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.